Nanotechnology has emerged as a transformative force in pharmaceutical research, offering innovative solutions to longstanding challenges in drug delivery, diagnostics, and tissue engineering. This chapter presents a comprehensive overview of recent advancements and optimization strategies in nano-enabled materials within the pharmaceutical field. Nano-enabled materials, including nanoparticles, liposomes, dendrimers, and nanofibers, exhibit unique physicochemical properties that can be tailored to enhance drug solubility, stability, and targeting specificity. Innovations in surface modification, functionalization, and ligand conjugation have enabled the optimization of nano-enabled materials for improved biocompatibility and therapeutic efficacy. Moreover, the integration of nanotechnology with other disciplines such as biotechnology and materials science has facilitated the development of multifunctional nanomaterials capable of synergistic drug delivery and imaging. However, challenges such as scalability, reproducibility, and regulatory considerations continue to impede the widespread clinical translation of nano-enabled materials. Addressing these challenges requires interdisciplinary collaboration and robust quality control measures to ensure the safety and efficacy of nano-enabled pharmaceutical products. By elucidating the latest trends and challenges in nano-enabled materials, this chapter aims to provide valuable insights for researchers, clinicians, and industry stakeholders striving to harness the full potential of nanotechnology in pharmaceutical applications. Nano-enabled materials in pharmaceuticals is expected to revolutionize drug delivery, diagnostics, and regenerative medicine, paving the way for more targeted, effective, and personalized healthcare interventions.